Building a hit list for the fight against metastatic castration resistant prostate cancer.

Cancer Biol Ther

a Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda , MD , USA.

Published: July 2016

Identification of genetic alterations in Metastatic Castration Resistant Prostate Cancer (mCRPC) may provide scientists and clinicians with a list of new targets for drug research and development. Recently published in Cell, Robinson et al. present the first look at genetic data from mCRPC lesions gathered over multiple years and from many institutions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847990PMC
http://dx.doi.org/10.1080/15384047.2016.1139270DOI Listing

Publication Analysis

Top Keywords

metastatic castration
8
castration resistant
8
resistant prostate
8
prostate cancer
8
building hit
4
hit list
4
list fight
4
fight metastatic
4
cancer identification
4
identification genetic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!